XORTX Therapeutics Inc. filed a Form 6-K on May 15, 2024, reporting its foreign issuer status and providing financial statements and management analysis for Q1 2024. Significant event due to reporting requirements; sentiment is neutral.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.